Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Pineapple flower (Ananas comosus) is the primary source of bromelain, a proteolytic enzyme complex with clinically demonstrated anti-inflammatory, immunomodulatory, and digestive-enhancing properties supported by a 2023 systematic review and meta-analysis confirming its efficacy in reducing pain and inflammation (PMID 37157782). Rich in vitamin C, manganese, flavonoids, and phenolic compounds, pineapple-derived bromelain exhibits good oral bioavailability with systemic absorption of intact enzymes, modulating key inflammatory mediators including NF-κB, COX-2, and prostaglandin E2 pathways (PMID 38999808; PMID 37650738).
Reported Benefits (Provisional)
Origin & History
Ananas comosus, commonly known as Pineapple, is a tropical fruit native to South America, particularly Brazil and Paraguay. It thrives in well-drained, nutrient-rich soils and abundant sunlight. Revered in Indigenous Amazonian and Caribbean herbal medicine, pineapple is a powerhouse of enzymes, antioxidants, and essential nutrients, valued for its digestive, immune-boosting, and anti-inflammatory properties.
Research Narrative (Provisional)
A 2023 systematic review and meta-analysis by Leelakanok et al. in Nutrition & Health (PMID 37157782) evaluated bromelain's efficacy and safety across multiple randomized controlled trials, confirming significant reductions in pain, swelling, and inflammation compared to placebo. Kansakar et al. (2024) published a comprehensive review in Nutrients (PMID 38999808) documenting bromelain's therapeutic potential across digestive disorders, osteoarthritis, cardiovascular disease, and immune modulation. Hikisz and Sadowska (2021) in Nutrients (PMID 34959865) detailed bromelain's beneficial properties including anti-cancer, anti-thrombotic, and fibrinolytic activities in both in vitro and in vivo models. Kumar et al. (2023) in Food & Function (PMID 37650738) provided a mechanistic review confirming bromelain's pharmacological effects on NF-κB signaling, platelet aggregation, and mucosal immunity across over 1,600 clinical and preclinical references.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Enzymes: Bromelain. - Phytochemicals: Flavonoids, carotenoids, polyphenols, pectin. - Vitamins: Vitamin C, Beta-carotene. - Minerals: Manganese, Potassium, Magnesium, Calcium, Phosphorus. - Other: Dietary fiber.
Reported Mechanism (Provisional)
Bromelain exerts its anti-inflammatory effects primarily by inhibiting the NF-κB signaling pathway, thereby downregulating the expression of pro-inflammatory mediators including cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), tumor necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β) (PMID 38999808; PMID 37650738). As a cysteine protease complex, bromelain directly hydrolyzes cell-surface receptors such as CD44, CD25, and CD45, modulating T-cell and macrophage activation and reducing leukocyte adhesion to endothelial cells (PMID 34959865; PMID 11577981). Its fibrinolytic activity involves the degradation of fibrin and reduction of plasma fibrinogen levels, inhibiting thromboxane A2-mediated platelet aggregation, which underlies its cardiovascular protective effects (PMID 34681298). Oral bioavailability studies confirm that bromelain is absorbed intact through the gastrointestinal mucosa, reaching peak plasma concentrations within 1–2 hours and retaining systemic proteolytic activity (PMID 11577981; PMID 37650738).
Clinical Narrative (Provisional)
Laboratory studies demonstrate pineapple extracts achieve 68.96% DPPH scavenging activity and 54.99% α-glucosidase inhibition in vitro. Anti-inflammatory studies using fermentation with Lactobacillus plantarum show significant reduction in inflammatory markers TNF-α and IL-6. However, comprehensive human clinical trials with large sample sizes are lacking, limiting evidence for therapeutic efficacy in clinical populations. Current evidence relies primarily on in vitro and animal studies rather than controlled human trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.